Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
Rallybio’s $50 Million Common Stock Offering
Rallybio’s Acquisition of Worldwide License Rights to KY 1066
Wiggin and Dana represented Rallybio Corporation on the acquisition. Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming...